A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2002
08/29/2002	WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same
08/29/2002	WO2002065963A1 Biodegradable cationic copolymers of poly(alkylenimine) and poly(ethylene glycol) for the delivery of bioactive agents
08/29/2002	WO2002065959A1 Urine incontinence device and corresponding method
08/29/2002	WO2002065943A2 Ocular tear growth factor-like protein
08/29/2002	WO2002065859A1 Emulsions and aqueous dispersions of phytosterols
08/29/2002	WO2002065834A2 Novel formulations of carvedilol
08/29/2002	WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
08/29/2002	WO2002045753A3 Oral extended release formulation of gepirone
08/29/2002	WO2002045571A3 Fast dissolving tablet
08/29/2002	WO2002041925B1 Sterilisation of pharmaceuticals
08/29/2002	WO2002036096A8 Non-aspirating transitional viscoelastics for use in surgery
08/29/2002	WO2002028422A3 Split enveloped virus preparation for intranasal delivery
08/29/2002	WO2002013671A3 Drug release (delivery system)
08/29/2002	WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002	WO2001097805A3 Solid valsartan pharmaceutical compositions
08/29/2002	WO2001089455A3 System and method for assessing the performance of a pharmaceutical agent delivery system
08/29/2002	WO2001085093A3 Compounds and methods for modulating cerebral amyloid angiopathy
08/29/2002	WO2001070206A3 Combination of lecithin with ascorbic acid
08/29/2002	WO2001068053A3 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
08/29/2002	WO2001041758A8 Valnemulin formulation
08/29/2002	WO2001035941A8 Novel composition based on a thiazolidinedione and metformin and use
08/29/2002	WO2001032158A3 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent
08/29/2002	WO2001005373A9 Methods and apparatus for preparation of lipid vesicles
08/29/2002	WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery
08/29/2002	WO2000061788A3 Poly(dipeptide) as a drug carrier
08/29/2002	WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof
08/29/2002	WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
08/29/2002	US20020120296 Implantable device using ultra-nanocrystalline diamond
08/29/2002	US20020120251 Implantable system for cell growth control
08/29/2002	US20020120228 Powder compositions
08/29/2002	US20020120147 Micronized torsemide
08/29/2002	US20020120015 Emulsification with a long chain polymer surfactant and a short chain fatty acid surfactant; thermodynamic stability
08/29/2002	US20020120009 Compounds and compositions for delivering active agents
08/29/2002	US20020119997 Aqueous solution; topical applying
08/29/2002	US20020119990 Liposomal camptothecins and uses thereof
08/29/2002	US20020119987 Analgesics, anesthetic; side effect reduction
08/29/2002	US20020119979 Cancer therapy
08/29/2002	US20020119969 Potassium channel modulator; antidiabetic agents
08/29/2002	US20020119960 Drug resistance therapy
08/29/2002	US20020119956 Using thalidomine
08/29/2002	US20020119949 Prophylactic teat treatment
08/29/2002	US20020119941 In-situ gel formation of pectin
08/29/2002	US20020119939 Stable aqueous deoxyfructosazine solution
08/29/2002	US20020119923 Administering macrophage derived compound
08/29/2002	US20020119916 Emulsion; therapy, diagnosis
08/29/2002	US20020119912 Synergistic mixture; therapy for psychological disorders
08/29/2002	US20020119910 Drug delivery
08/29/2002	US20020119239 Acidic oil-in-water type emulsion composition
08/29/2002	US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms
08/29/2002	US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions
08/29/2002	US20020119203 Preparing first phase comprising nucleophilic active agent, a polymer and solvent; combining with second phase in a static mixer to form emulsion; extracting solvent from the emulsion, thereby forming microparticles
08/29/2002	US20020119202 For therapy of cancer and other angiogenic-dependent diseases
08/29/2002	US20020119200 Dispersing drug in a suitable volume of a liquid dispersion medium to form a suspension; bringing together in a vessel grinding media, magnetically activatable means for stirring and the suspension; magnetically activating; separation
08/29/2002	US20020119199 Fenofibrate microparticles
08/29/2002	US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment
08/29/2002	US20020119197 For providing uniform dosing over a prolonged period following a single administration
08/29/2002	US20020119196 May be used to make chewable tablets or rapidly disintegrating tablets that conveniently may be administered without water
08/29/2002	US20020119195 Rapidly disintegrating sustained release cefuroxime axetil composition
08/29/2002	US20020119194 Pharmaceutical forms for the oral administration of mesna
08/29/2002	US20020119193 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/29/2002	US20020119192 Controlled release formulations for oral administration
08/29/2002	US20020119191 Pharmaceutical or food composition for treatment or prevention of brain edema
08/29/2002	US20020119190 Oil-free pharmaceutical compositions containing cyclosporin A
08/29/2002	US20020119188 Method of manufacturing liposomes
08/29/2002	US20020119187 Useful to induce analgesia
08/29/2002	US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source
08/29/2002	US20020119185 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
08/29/2002	US20020119183 Mineral supplement
08/29/2002	US20020119176 Implantable microfluidic delivery system using ultra-nanocrystalline diamond coating
08/29/2002	US20020119170 Drug delivery, efficiency
08/29/2002	US20020119169 For use in cosmetic applications, applications in crop protection, for cleaners or food supplements
08/29/2002	US20020119149 Multivalent T cell receptor complexes
08/29/2002	US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents
08/29/2002	US20020119134 For prophylaxis and therapy of vaginal infections
08/29/2002	US20020119133 Use of bacterial phage associated lysing enzymes for treating various illnesses
08/29/2002	US20020119132 Use of bacterial phage associated lysing enzymes for treating various illnesses
08/29/2002	US20020119131 Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses
08/29/2002	US20020119125 Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain
08/29/2002	US20020119117 Modulated release particles for aerosol delivery
08/29/2002	US20020119110 Cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating
08/29/2002	US20020119104 Treatment of mucositis
08/29/2002	US20020119103 Stability, uniformity
08/29/2002	US20020117175 Thermal vaporizing device for drug delivery
08/29/2002	US20020117170 Compositions and methods for the pulmonary delivery of aerosolized macromolecules
08/29/2002	DE10164343A1 Tablettierfähige Zusammensetzung mit Natrium Fosinopril Tabletting flowing composition with fosinopril sodium
08/29/2002	DE10108387A1 Kosmetisches oder pharmazeutisches Mittel Cosmetic or pharmaceutical composition
08/29/2002	DE10107240A1 Gelemulsionen in Form von O/W-Emulsionen mit einem Gehalt an Hydrokolloiden Gel emulsions in the form of O / W emulsions with a content of hydrocolloids
08/29/2002	DE10107165A1 Thermolabiles Liposom mit geregelter Freigabetemperatur Thermolabile liposome with controlled release temperature
08/29/2002	DE10106971A1 Arzneimittelformulierung die einen muskarinischen Agonisten enthält Pharmaceutical formulation containing a muscarinic agonist
08/29/2002	DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use
08/29/2002	CA2438519A1 Emulsions and aqueous dispersions of phytosterols
08/29/2002	CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity
08/29/2002	CA2437242A1 Tramadol-based medicament
08/29/2002	CA2437168A1 Retinoid hepatitis therapy
08/29/2002	CA2435378A1 Urine incontinence device and corresponding method
08/29/2002	CA2434647A1 Cubic liquid crystalline compositions and methods for their preparation
08/29/2002	CA2426811A1 Novel formulations of carvedilol
08/28/2002	EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
08/28/2002	EP1234586A2 Hepatoselective pharmaceutical actives
08/28/2002	EP1234573A1 Anti-inflammatory pharmaceutical compositions and their manufacturing process

1 ... 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 ... 2991